[HTML][HTML] SARS-CoV-2 Omicron variant neutralization in serum from vaccinated and convalescent persons
In Vitro Neutralization of Omicron Variant Serum from vaccinated persons was assayed for
ability to neutralize the omicron variant of SARS-CoV-2. Persons who had received two doses …
ability to neutralize the omicron variant of SARS-CoV-2. Persons who had received two doses …
ADAM10 and ADAM17 promote SARS‐CoV‐2 cell entry and spike protein‐mediated lung cell fusion
G Jocher, V Grass, SK Tschirner, L Riepler… - EMBO …, 2022 - embopress.org
The severe‐acute‐respiratory‐syndrome‐coronavirus‐2 (SARS‐CoV‐2) is the causative
agent of COVID‐19, but host cell factors contributing to COVID‐19 pathogenesis remain only …
agent of COVID‐19, but host cell factors contributing to COVID‐19 pathogenesis remain only …
[HTML][HTML] Comparison of four SARS-CoV-2 neutralization assays
L Riepler, A Rössler, A Falch, A Volland, W Borena… - Vaccines, 2020 - mdpi.com
Neutralizing antibodies are a major correlate of protection for many viruses including the
novel coronavirus SARS-CoV-2. Thus, vaccine candidates should potently induce neutralizing …
novel coronavirus SARS-CoV-2. Thus, vaccine candidates should potently induce neutralizing …
SARS-CoV-2 B. 1.1. 529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals
A Roessler, L Riepler, D Bante, D von Laer, J Kimpel - MedRxiv, 2021 - medrxiv.org
Recently, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant B.1.1.529
(Omicron) has been described. Here, we analyze titers of neutralizing antibodies of sera …
(Omicron) has been described. Here, we analyze titers of neutralizing antibodies of sera …
[HTML][HTML] Heterologous ChAdOx1/BNT162b2 vaccination induces stronger immune response than homologous ChAdOx1 vaccination: the pragmatic, multi-center, three …
Background Several COVID-19 vaccines have been approved. The mRNA vaccine from
Pfizer/BioNTech (Comirnaty, BNT162b2; BNT) and the vector vaccine from AstraZeneca (…
Pfizer/BioNTech (Comirnaty, BNT162b2; BNT) and the vector vaccine from AstraZeneca (…
[HTML][HTML] High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl
… Lydia Riepler … Ludwig Knabl, Janine Kimpel, Annika Rössler, André Volland, Lisa Pipperger,
Lydia Riepler, Barbara Falkensammer, Wegene Borena & Dorothee von Laer … Lydia Riepler …
Lydia Riepler, Barbara Falkensammer, Wegene Borena & Dorothee von Laer … Lydia Riepler …
Marked increase in avidity of SARS-CoV-2 antibodies 7–8 months after infection is not diminished in old age
…, J Kimpel, A Rössler, L Riepler… - The Journal of …, 2021 - academic.oup.com
The kinetics of immunoglobulin G (IgG) avidity maturation during severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2) infection obtained from 217 participants of the Ischgl …
syndrome coronavirus-2 (SARS-CoV-2) infection obtained from 217 participants of the Ischgl …
[HTML][HTML] Therapeutic efficacy of a VSV-GP-based human papilloma virus vaccine in a murine cancer model
L Riepler, LS Frommelt, S Wilmschen-Tober… - Journal of Molecular …, 2023 - Elsevier
Human papilloma virus (HPV) infections are associated with almost all cervical cancers and
to a lower extend also with anogenital or oropharyngeal cancers. HPV proteins expressed in …
to a lower extend also with anogenital or oropharyngeal cancers. HPV proteins expressed in …
[HTML][HTML] Persistence of immunity to SARS-CoV-2 over time in the ski resort Ischgl
W Borena, Z Bánki, K Bates, H Winner, L Riepler… - …, 2021 - thelancet.com
Background In early March 2020, a SARS-CoV-2 outbreak in the ski resort Ischgl in Austria
triggered the spread of SARS-CoV-2 throughout Austria and Northern Europe. In a previous …
triggered the spread of SARS-CoV-2 throughout Austria and Northern Europe. In a previous …
[HTML][HTML] Seroprevalence of SARS-CoV-2 infection in the Tyrolean district of Schwaz at the time of the rapid mass vaccination in March 2021 following B. 1.351-variant …
…, B Falkensammer, A Rössler, L Riepler… - Frontiers in Public …, 2022 - frontiersin.org
In order to curb the rapid dissemination of the B.1.351 variant of SARS-CoV-2 in the district
of Schwaz and beyond, the EU allocated additional vaccine doses at the beginning of March …
of Schwaz and beyond, the EU allocated additional vaccine doses at the beginning of March …